Abstract
Dengue virus infections are increasing at an alarming rate in many tropical and subtropical countries and represent, in some of these areas, a leading cause of hospitalization and death among children. The lack of a clear definition of the correlates of protection from severe dengue disease represents a major hurdle for vaccine development. In particular, the role of T lymphocytes during dengue infection remains unclear and there is evidence suggesting that these cells may be important for both protective immunity and/or immunopathology. In this review we discuss the findings that support a protective role of T cells versus those supporting their involvement in pathogenesis. A better understanding of T cell immunity is urgently needed for the development of safe and efficacious vaccines.
| Original language | English |
|---|---|
| Pages (from-to) | 443-53 |
| Number of pages | 11 |
| Journal | Expert Review of Vaccines |
| Volume | 15 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 2016 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Animals
- Dengue/immunology
- Dengue Vaccines/immunology
- Dengue Virus/immunology
- Disease Models, Animal
- Drug Discovery/methods
- Humans
- T-Lymphocytes/immunology
Fingerprint
Dive into the research topics of 'T cell immunity to dengue virus and implications for vaccine design'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver